VDR and chronic kidney disease: This 25(OH)D/calcitriol synergy, achieved by normalizing serum 25(OH)D levels, was shown sufficient to overcome the parathyroid resistance to low doses of the calcitriol analog paricalcitol caused by VDR reductions and accumulation of uremic toxins, even in hyper-phosphatemic experimental CKD (38).